- Cannara Biotech (OTC:CNBTF): Q2 GAAP EPS of -$0.01.
- Revenue of $0.51M
- Press Release
- More news on: Cannara Biotech Inc., Earnings news and commentary, ,
home / stock / cnbtf / cnbtf news
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Appoints Dr. Sara May to its Board of Directors Canada NewsWire VANCOUVER, May 24, 2019 VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: CNBTF), an emerging vertically integrated cannabis c...
Cannara Biotech Commences Trading on the OTCQB Market in the United States Canada NewsWire VANCOUVER, May 15, 2019 VANCOUVER , May 15, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: CNBTF), an emerging vertically integrated cannab...
VANCOUVER , April 29, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets...